Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for preventing stroke

M C Kanter1, D G Sherman

  • 1Department of Medicine (Neurology), University of Texas Health Science Center, San Antonio 78284-7883.

Current Opinion in Neurology and Neurosurgery
|February 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discussion: Reconsideration of TIA terminology and definitions.

Neurology·2004
Same author

Antithrombotic therapy in the acute phase: new approaches.

Cerebrovascular diseases (Basel, Switzerland)·2001
Same author

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

Circulation·2001
Same author

Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

Stroke·2001
Same author

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial.

JAMA·2000
Same author

Prevention of stroke in patients with nonvalvular atrial fibrillation.

Neurology·1998
Same journal

Neuropharmacology.

Current opinion in neurology and neurosurgery·1993
Same journal

Disorders of the spinal cord and cauda equina.

Current opinion in neurology and neurosurgery·1993
Same journal

Autonomic disorders.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular and cell biology of addiction.

Current opinion in neurology and neurosurgery·1993
Same journal

Molecular mechanisms of trauma-induced neuronal degeneration.

Current opinion in neurology and neurosurgery·1993
Same journal

Excitatory amino acid receptors and epilepsy.

Current opinion in neurology and neurosurgery·1993
See all related articles

Preventing stroke is crucial due to limited acute stroke therapies. Managing modifiable risk factors like hypertension and diabetes, alongside specific treatments for conditions like atrial fibrillation, is key to reducing stroke incidence and recurrence.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Current therapies for acute stroke have limited effectiveness.
  • Stroke prevention strategies are therefore of paramount importance.
  • Identifying and managing risk factors is essential for reducing stroke incidence.

Purpose of the Study:

  • To outline key strategies for stroke prevention.
  • To emphasize the management of modifiable risk factors.
  • To highlight specific interventions for high-risk patient groups.

Main Methods:

  • Review of established risk factors for stroke.
  • Discussion of management strategies for modifiable risk factors including hypertension, smoking, hyperlipidemia, and diabetes.
  • Consideration of therapeutic options for patients at risk of recurrent stroke, such as antithrombotic therapy and carotid endarterectomy.

Related Experiment Videos

  • Emphasis on the role of managing nonvalvular atrial fibrillation and other cardiac, malignant, and hematologic disorders.

    • Main Results:

    • Hypertension, smoking, hyperlipidemia, and diabetes are significant modifiable risk factors.
    • Antithrombotic therapy and carotid endarterectomy are recommended for patients with transient ischemic attacks or stroke.
    • Antithrombotic therapy is indicated for patients with nonvalvular atrial fibrillation.
    • Management of cardiac, malignant, and hematologic disorders is vital for stroke prevention in high-risk individuals.

    Conclusions:

    • Stroke prevention requires a multifaceted approach focusing on risk factor management.
    • Targeted therapies for specific conditions like atrial fibrillation significantly reduce stroke risk.
    • Comprehensive management of underlying health disorders is critical for preventing stroke in vulnerable populations.